Baylor Genetics

Yesterday was World Sickle Cell Day. Did you know that sickle cell disease (SCD) affects about 100,000 Americans and millions worldwide? SCD is an inherited blood condition that causes crescent-shaped red blood cells and impacts oxygen transportation in the body. Early detection of SCD through a simple blood test can lower the risk for complications.

We can help assess the risk for SCD with our carrier screening panel, GeneAwareTM, which screens for SCD.

Learn more: https://bit.ly/425hZIg

Today and always, we honor the sacrifices of those who have paved the way for freedom. We stand in solidarity, united in our pursuit of a future where everyone is truly free, and where equity and harmony prevail.

Whole Exome Sequencing (WES) examines the protein-coding parts of your genome, where 85% of disease-causing variants are found.

Our WES holds the potential to identify these variants and is a recommended first-tier test for certain pediatric conditions.

Learn more: https://bit.ly/46dTz2N

Baylor Genetics was a proud sponsor of this year’s Seattle Children's ! It was great connecting with our peers and learning about new tools and opportunities in laboratory stewardship, insurance alignment, and more. We hope to see you again next year!

To fathers, grandfathers, uncles, mentors, and all those who play a fatherly role in our lives, Happy Father's Day! Thank you for your love, guidance, and support.

We’re seeking a Senior Software Architect Engineer! In this role, your primary focus will revolve around creating software solutions with a commitment to quality and reliability, helping shape the precision, efficiency, and accessibility of our medical testing solutions.

Interested? Learn more: https://bit.ly/3x2mzh7

Optimal patient care starts with choosing the right tests. Our Connective Tissue Disorders Panel analyzes the most impactful genes related to multisystemic conditions that affect the body's soft connective tissue. With our targeted and precise testing, you can ensure the best possible care for your diagnostic needs.

Learn more: https://bit.ly/4bv507R

Mitochondria is the powerhouse of eukaryotic cells, and they generate energy vital for muscle movement and brain function. Understanding mitochondria's role can be crucial for comprehending health and disease.

Our mitochondrial testing identifies genetic variants linked to mitochondrial conditions, guiding personalized treatments and improving patient health.

Learn more: https://bit.ly/4bmESwB

A newborn patient exhibited an array of symptoms including developmental delay, weak muscle tone, and feeding difficulties. ​

Baylor Genetics’ Rapid Whole Genome Sequencing (rWGS) helped uncover the newborns’ underlying genetic cause, revealing a complex chromosome rearrangement and a diagnosis of Prader-Willi Syndrome. ​

The case demonstrates the valuable role of rWGS in uncovering complex chromosome patterns and guiding personalized care for patients.​

Learn more: https://bit.ly/3IcZomA​

Improving patient outcomes is at the core of who we are at Baylor Genetics. During National Cancer Survivors Month, we honor all patients and survivors, recognizing their journey's challenges and celebrating their resilience. Proactive measures such as early detection can empower patients to make informed decisions about their health.​

June is Pride Month dedicated to honoring the LGBTQ+ community and celebrating the strides towards equality and acceptance. This month and all year, we champion diversity and inclusion, celebrating the individual identities within our team. Committed to equitable care, we empower our patients and providers, ensuring they receive the attention and care they deserve, regardless of identity. By breaking barriers, we embody the change we wish to see.​

Learn more about Pride Month: https://bit.ly/3KnuPLO

Cystic fibrosis (CF) is a genetic condition caused by biallelic pathogenic variants in the CFTR gene. It is characterized by progressive respiratory damage due to a thick mucus buildup in the lungs and chronic digestive system problems.​

Baylor Genetics is committed to empowering providers to deliver the best care possible for their patients with CF. Did you know, we screen for CF in our universal carrier screening panel, GeneAware?​

Learn more: http://bit.ly/3cyZnYS ​

On Mother's Day, we extend our gratitude to all the caregivers who play pivotal roles in our lives. Whether it's a mother, grandmother, aunt, sister, or friend, caregivers selflessly give their time, energy, and love to ensure the well-being of others.

Have you ever wondered what "out-of-pocket maximum" or "premium" really means in your health insurance plan? This blog demystifies these terms (and others!) to help you navigate your health insurance options. Like how understanding your genetics can guide health decisions, knowing your insurance terms can optimize your coverage. ​

Learn more: https://www.baylorgenetics.com/news/defining-terms-in-health-insurance/

Defining Terms in Health Insurance - Baylor Genetics Decode confusing terms and acronyms to understand your out-of-pocket costs.

We're pleased to welcome Baylor Genetics as a 2024 Conference Silver Sponsor! Thank you for your dedication to the mito community. Learn more about becoming a conference sponsor at umdfconference.org

We’re seeking a Biochemical Genetic Technologist proficient in conducting multiple genetic tests including Tay-Sachs and Amino Acid analysis. You’ll handle sample processing and assess suitability for downstream applications.

Does this sound like you? Learn more: https://bit.ly/4cV6pWP

Happy National DNA Day! Today celebrates the discovery of DNA's double helix in 1953 and the completion of the Human Genome Project in 2003, pivotal moments that revolutionized genetics.

At Baylor Genetics, we are committed to transforming healthcare and improving patient outcomes by empowering patients and providers with answers that matter.

Our Neuromuscular Disorders Panel is designed to assess 142 genes linked with neuromuscular conditions including congenital myasthenic syndrome, limb-girdle muscular dystrophy, and congenital muscular dystrophies.

Our team of genetic counselors and experts offer support at every stage, ensuring that all questions are thoroughly addressed.

Learn more: https://bit.ly/3OGYQt1

We're seeking a Project Manager, Lab Support. In this role you’ll plan, coordinate, and track project progress for optimal outcomes. Additionally, you will play a pivotal role in aligning objectives by leading project team meetings and managing project risk and critical path items for smooth progress and success.

Join our team and be part of our mission to advance patient care.

Learn more: https://bit.ly/3TX5vjR

Our Chromosomal Microarray Analysis (CMA) detects pathogenic copy number variants, revealing diagnoses for both common chromosomal conditions and severe genetic disorders. With its unparalleled ability to detect these variants, CMA offers a unique advantage over traditional chromosome analysis and panel testing.

For details, visit: https://bit.ly/3ZEvXRW

We're thrilled to celebrate Medical Laboratory Professional Week, recognizing the significant influence clinical laboratory professionals have on public health, patient care, and their indispensable contributions to the clinical and diagnostic sciences. This year's theme is, "The Lab is Everything!" The laboratory is at the core of all medicine, where critical diagnoses are made.

During this week, and all year, Baylor Genetics celebrates our lab professionals including pathologists, lab technicians, and medical genetic technologists, for their commitment and dedication to improving the well-being of families and the community.

We're seeking a Regional Account Director specializing in managed care to join our team. In this role, you will lead negotiations with regional health plans and facilitate cross-functional collaboration with internal departments. Other responsibilities include analyzing contract proposals and ensuring contract compliance.

Does this sound like the right opportunity for you? Learn more: https://bit.ly/3VDmMBg

Today marks World Parkinson’s Day. Parkinson's disease (PD) stands as the second-most common neurodegenerative condition in the US and primarily affects dopamine-producing neurons in a certain part of the brain.

Early detection, tailored treatment, and on-going support are crucial for effectively addressing symptoms and fostering care for individuals with PD. Baylor Genetics supports providers and their patients in navigating the diagnostic journey with comprehensive genetic testing to enhance clinical management and improve patient outcomes.

For newborns and children in the NICU/PICU with complex medical issues, Rapid Whole Exome Sequencing (rWES) can be critical to a timely and accurate diagnosis.

Visit our website to learn how our rWES is improving patient outcomes: https://bit.ly/3Hw1UUJ

Autism Spectrum Disorder (ASD) is a group of neurodevelopmental conditions that can lead to notable social, communication, and behavioral challenges. Raising awareness and fostering understanding are essential steps towards building a more inclusive and supportive society for autistic individuals.

Baylor Genetics’ Neurodevelopmental Disorders Panel analyzes 236 genes associated with syndromic and non-syndromic ASD, intellectual disability, and developmental delay. Early detection through genetic testing can guide personalized interventions.

Learn more: https://lnkd.in/gXHcpfDU

A recent study discovered rare variants in the YKT6 gene as the cause of a new neurological disorder characterized by developmental delays along with severe progressive liver disease and a potential risk for liver cancer, marking the first time the YKT6 gene has been linked to a genetically inherited disorder.

This important discovery to improve patient outcomes was made possible due to the collaboration between Baylor College of Medicine, Baylor Genetics, Texas Children's Hospital, and Columbia University Irving Medical Center.

Read the article on Medical Express:

YKT6 gene variants cause a new neurological disorder, finds study A recent collaborative study has discovered rare variants in the YKT6 gene as the cause of a new neurological disorder characterized by developmental delays along with severe progressive liver disease and a potential risk for liver cancer.

Patient centricity is at the core of our mission as we seek skilled Molecular Genetic Technologists specializing in next-generation sequencing across various levels based on experience to join our team. As a genetic technologist, you will play a pivotal role in conducting high-complexity molecular tests to aid in the treatment and diagnosis of genetic diseases. Responsibilities include troubleshooting assay performance and operating and maintaining laboratory equipment while adhering to 5S standards.

If you are passionate about molecular diagnostics and are committed to making a difference in patient care, we encourage you to apply for this position.

Learn more: https://bit.ly/48MwsNk

We’re dedicated to equipping healthcare providers with solutions to meet the individual needs of each patient. Our BluePrint Panel examines the exonic region of up to 1,000 genes in a single comprehensive test, identifying rare DNA variations that could contribute to or directly lead to your patient's medical condition.

Visit our website to request this customizable test: https://bit.ly/42CoN1Z

A 2-week-old newborn in the pediatric intensive care unit presented with a perplexing array of symptoms including muscle weakness, low blood sugar levels, and elevated carbon dioxide levels, accompanied by respiratory distress leading to respiratory failure. Recognizing the urgency of the situation, the healthcare team turned to Baylor Genetics’ Rapid Whole Genome Sequencing (rWGS) to help provide a diagnosis.

With the aid of rWGS, a single nucleotide variant (SNV) and a copy number variant (CNV) were identified within the DOK7 gene, marking a pivotal breakthrough.

Read more about this case and the utility of rWGS as a first-tier test in the NICU: https://bit.ly/3IcZomA

For more details about our rWGS, visit: https://bit.ly/42iERVj